323.00
-12.50
(-3.73%)
At close: January 10 at 3:29:52 PM GMT+5:30
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
1,543,185.00
1,698,081.00
1,481,297.00
1,141,917.00
904,250.00
Cost of Revenue
327,672.00
416,075.00
307,810.00
208,921.00
211,075.00
Gross Profit
1,215,513.00
1,282,006.00
1,173,487.00
932,996.00
693,175.00
Operating Expense
531,648.00
526,660.00
448,379.00
367,252.00
297,682.00
Operating Income
683,865.00
755,346.00
725,108.00
565,744.00
395,493.00
Net Non Operating Interest Income Expense
37,338.00
38,060.00
49,529.00
24,332.00
11,695.00
Pretax Income
706,932.00
793,343.00
774,648.00
590,345.00
408,819.00
Tax Provision
179,924.00
201,711.00
194,960.00
154,103.00
107,023.00
Net Income Common Stockholders
527,028.00
591,632.00
579,688.00
436,242.00
301,797.00
Diluted NI Available to Com Stockholders
527,028.00
591,632.00
579,688.00
436,242.00
301,797.00
Basic EPS
4.83
5.43
5.32
4.00
2.77
Diluted EPS
4.83
5.43
5.32
4.00
2.77
Basic Average Shares
109,128.53
108,965.27
108,965.27
108,965.27
108,965.27
Diluted Average Shares
109,128.53
108,965.27
108,965.27
108,965.27
108,965.27
Rent Expense Supplemental
--
1,786.00
1,540.00
827.00
2,833.00
Total Expenses
859,320.00
942,735.00
756,189.00
576,173.00
508,757.00
Net Income from Continuing & Discontinued Operation
527,028.00
591,632.00
579,688.00
436,242.00
301,797.00
Normalized Income
527,028.00
591,632.00
579,688.00
436,639.56
301,755.66
Interest Income
--
40,351.00
51,290.00
32,610.00
21,509.00
Interest Expense
2,147.00
1,425.00
948.00
7,328.00
7,895.00
Net Interest Income
37,338.00
38,060.00
49,529.00
24,332.00
11,695.00
EBIT
709,079.00
794,768.00
775,596.00
597,673.00
416,714.00
EBITDA
761,064.00
835,403.00
801,353.00
620,003.00
434,039.00
Reconciled Cost of Revenue
327,672.00
416,075.00
307,810.00
208,921.00
211,075.00
Reconciled Depreciation
51,985.00
40,635.00
25,757.00
22,330.00
17,325.00
Net Income from Continuing Operation Net Minority Interest
527,028.00
591,632.00
579,688.00
436,242.00
301,797.00
Total Unusual Items Excluding Goodwill
--
--
--
-538.00
56.00
Total Unusual Items
--
--
--
-538.00
56.00
Normalized EBITDA
761,064.00
835,403.00
801,353.00
620,541.00
433,983.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
--
--
--
-140.44
14.66
3/31/2021 - 12/30/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
THEMISMED.BO Themis Medicare Limited
261.60
-3.88%
WINDLAS.BO Windlas Biotech Limited
985.55
-2.93%
NECLIFE.NS Nectar Lifesciences Limited
38.25
+0.84%
SGRL.BO Shree Ganesh Remedies Limited
690.00
+3.10%
MANKIND.BO Mankind Pharma Limited
2,749.00
-2.82%
AARTIPHARM.NS Aarti Pharmalabs Limited
670.00
+1.49%
CAPLIPOINT.NS Caplin Point Laboratories Limited
2,365.05
-4.54%
PPLPHARMA.NS Piramal Pharma Limited
225.05
-5.10%